Stage I and II aggressive B-cell lymphomas of the head and neck: Radiotherapy alone as a treatment option and the usefulness of the new prognostic index B-ALPS

International Journal of Radiation Oncology Biology Physics

Volumn 55, Issue 1, 2003, Pages 44-50

  Hayabuchi, Naofumi ^a   Shibamoto, Yuta ^b   Nakamura, Katsumasa ^c   Onizuka, Yoshihiko ^d   Ogo, Etsuyo ^a   Suzuki, Gen ^a   Toda, Yukihiro ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Head and neck; Lymphoma; Radiotherapy

Indexed keywords

CHEMOTHERAPY; DISEASES; PATIENT TREATMENT;

CHEMOTHERAPY REGIMENS;

RADIOTHERAPY;

ANTHRACYCLINE DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; LACTATE DEHYDROGENASE; MERCAPTOPURINE; PREDNISOLONE; PREDNISONE; VINCRISTINE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 0347298704     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)03798-7     Document Type: Article

References (22)

1. Hoppe R.T. The role of radiation therapy in the management of the non-Hodgkin's lymphomas. Cancer. 55:1985;2176-2183.
2. Sutcliffe S.B., Gospodarowicz M.K., Bush R.S., et al. Role of radiation therapy in localised non-Hodgkin's lymphoma. Radiother Oncol. 4:1985;211-223.
3. Hallahan D.E., Farah R., Vokes E.E., et al. The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. Int J Radiat Oncol Biol Phys. 17:1989;767-771.
4. Monfardini S., Banfi A., Bonadonna G., et al. Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 6:1980;125-134.
5. Nissen N.I., Ersboll J., Hansen H.S., et al. A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I-II non-Hodgkin's lymphomas. Cancer. 52:1983;1-7.
6. Cabanillas F., Bodey G.P., Freireich E.J. Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types. Cancer. 46:1980;2356-2359.
7. Miller T.P., Jones S.E. Is there a role for radiotherapy in localized diffuse lymphomas? Cancer Chemother Pharmacol. 4:1980;67-70.
8. Miller T.P., Dahlberg S., Cassady J.R., et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 339:1998;21-26.
9. Horning S.J., Glick J., Kim K., et al. Final report of E1484 CHOP v CHOP + radiotherapy (RT) for limited stage diffuse aggressive lymphoma . Blood. 98:2001;724a.
10. Tondini C., Zanini M., Lombardi F., et al. Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphoma. J Clin Oncol. 11:1993;720-725.
11. Tsang R.W., Gospodarowicz M.K. Non-Hodgkin's lymphoma. Gunderson L.L., Tepper J.E. Clinical radiation oncology. 2000;1158-1188 Churchill Livingstone, New York.
12. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 329:1993;987-994.
13. Oguchi M., Ikeda H., Isobe K., et al. Tumor balk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma A survey of the Japan Lymphoma Radiation Therapy Group . Int J Radiat Oncol Biol Phys. 48:2000;161-168.
14. Rodriguez J., Cabanillas F., MacLaughlin P., et al. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the "tumor score." Ann Oncol. 3:1992;711-717.
15. Fuller L.M., Krasin M.J., Velasquez W.S., et al. Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation. Int J Radiat Oncol Biol Phys. 31:1995;3-11.
16. Kamath S.S., Marcus R.B., Lynch J.W., et al. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 44:1999;536-568.
17. Wilder R.B., Tucker S.L., Ha C.S., et al. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy. Int J Radiat Oncol Biol Phys. 49:2001;17-22.
18. Shimoyama M. Peripheral T-cell lymphoma in Japan Recent progress . Ann Oncol. 2:(Suppl. 2):1991;157-162.
19. Sasai K., Yamabe H., Kokubo M., et al. Head-and-neck stages I and II extranodal non-Hodgkin's lymphomas REAL classification and selection for treatment modality . Int J Radiat Oncol Biol Phys. 48:2000;153-160.
20. Sunaba K., Shibuya H., Okada N., et al. Radiotherapy for primary localized (stage I and II) non-Hodgkin's lymphoma of the oral cavity. Int J Radiat Oncol Biol Phys. 47:2000;179-183.
21. Kim G.E., Lee S.W., Chang S.K., et al. Combined chemotherapy and radiation versus radiation alone in the management of localized angiocentric lymphoma of the head and neck. Radiother Oncol. 61:2001;261-269.
22. Shikama N., Ikeda H., Nakamura S., et al. Localized aggressive non-Hodgkin's lymphoma of the nasal cavity A survey by the Japan Lymphoma Radiation Therapy Group . Int J Radiat Oncol Biol Phys. 51:2001;1228-1233.